Well Told Grants

Federal grant recipients / Florida

Federal grants to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.

Tampa, Florida · Nonprofits · UEI DVHKP4N619V9

H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida received $332 million in federal grants from fiscal 2021 to 2025, across 246 awards. Its largest program was Cancer Biology Research, with $62.7 million. In fiscal 2025 it was awarded $80.5 million.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. by fiscal year
Fiscal yearAwardsAmount
FY 202195$47.2 million
FY 2022129$70.0 million
FY 2023129$70.6 million
FY 2024116$63.5 million
FY 202592$80.5 million

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.

The 10 largest programs, fiscal 2021 to 2025
ProgramAwardsAmount
Cancer Biology Research 93.39641$62.7 million
Military Medical Research and Development 12.42045$54.6 million
Cancer Treatment Research 93.39543$52.5 million
Cancer Cause and Prevention Research 93.39329$44.8 million
Cancer Centers Support Grants 93.3974$37.3 million
Cancer Detection and Diagnosis Research 93.39413$16.9 million
Biomedical Research and Research Training 93.8596$8.5 million
Cancer Research Manpower 93.39818$7.3 million
Oral Diseases and Disorders Research 93.1215$6.8 million
Congressional Directives 93.4933$6.0 million

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services196$274 million
Department of Defense45$54.6 million
Department of Commerce1$2.4 million
National Science Foundation4$1.2 million

Largest awards

The 10 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Moffitt cancer center support grant
ASST_NON_P30CA076292_075 on USAspending
Cancer Centers Support GrantsDecember 11, 2020$21.8 million
Using combinatorial therapies with dendritic cell therapies to improve survival and prevent recurrence of breast cancer leptomeningeal disease (LMD)
ASST_NON_HT94252520006_097 on USAspending
Military Medical Research and DevelopmentJuly 21, 2025$18.7 million
Identifying metabolic vulnerabilities in lung cancer - overall project summary identifying metabolic vulnerabilities in lung cancer lung cancer is the most common cause of cancer deaths world-wide. Tyrosine kinase inhibitors and immunotherapy have been shown to be effective in a subset of patients;
ASST_NON_P01CA250984_075 on USAspending
Cancer Biology ResearchJune 25, 2021$10.1 million
The delta ecology of nsclc treatment - summary – moffitt csbc proposal overview the moffitt csbc proposal is focused on the essential and highly dynamical interplay between cancer cell evolution and the constantly changing ecology of the lung microenvironment. Tumors are not simply collections of mu
ASST_NON_U54CA274507_075 on USAspending
Cancer Centers Support GrantsSeptember 15, 2023$6.3 million
Ponce school of medicine-moffitt cancer center partnership (2/2)
ASST_NON_U54CA163068_075 on USAspending
Cancer Centers Support GrantsJune 29, 2021$6.3 million
Moffitt imaging biomarker validation center
ASST_NON_U01CA200464_075 on USAspending
Cancer Detection and Diagnosis ResearchDecember 2, 2020$3.9 million
HIV genomic aging project in oncology (hiv-gap) - abstract. People with HIV (PWH) experience higher cancer mortality and increased likelihood of cancer relapse after initial therapy compared to hiv-uninfected cancer patients. Our prior work demonstrated that these hiv-associated cancer outcome dispa
ASST_NON_R01CA268973_075 on USAspending
Cancer Treatment ResearchSeptember 20, 2021$3.8 million
Advancing clinical trials: working through outreach, navigation and digital enabled referral and recruitment strategies (act wonders) - abstract limited participation of racial/ethnic minorities in therapeutic clinical trials perpetuates cancer care disparities. Not only do racial/ethnic minority pa
ASST_NON_U01CA274971_075 on USAspending
Cancer Cause and Prevention ResearchSeptember 8, 2022$3.7 million
Using radiogenomics to noninvasively predict the malignant potential of intraductal papillary mucinous neoplasms of the pancreas and uncover hidden biology
ASST_NON_R37CA229810_075 on USAspending
Cancer Detection and Diagnosis ResearchJune 8, 2021$3.6 million
Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and kras driven breast and lung cancers - project summary although the development of targeted therapies has improved overall cancer patient survival, adaptive responses by tumor cells can render these treatments ineffective. The de
ASST_NON_R01CA262530_075 on USAspending
Cancer Treatment ResearchJuly 12, 2021$3.5 million

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. get?

$332 million in 246 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. the most?

The Department of Health and Human Services, with $274 million in 196 awards. The Department of Defense and the Department of Commerce follow.

What is H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.'s largest federal grant?

$21.8 million under Cancer Centers Support Grants, with its first action in the period on December 11, 2020. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.?

Its largest are Cancer Biology Research, Military Medical Research and Development and Cancer Treatment Research.

Other grant recipients in Tampa

Largest federal grant recipients in Florida · Federal grants in Florida